BIODYNE CO., LTD.
Founded in 1999 and KOSDAQ-listed in 2021, BIODYNE develops liquid-based cytology (LBC) devices and diagnostic reagent kits.
As of 2026-10-11, BIODYNE CO., LTD. has 22 Korean MFDS device approvals, 1 PubMed-indexed paper on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 1999 and listed on KOSDAQ in 2021, BIODYNE is a liquid-based cytology (LBC) device and diagnostic reagent company. Using its proprietary Blowing Technology, it supplies LBC devices including PATHPLORER AUTO, PATHPLORER PLUS 4.7, PATHPLORER PLUS 4.63, and PATHPLORER ECO, along with reagent kits such as cell processing solutions, membrane filters, and slides. It exports to 13 countries including Japan, Russia, Portugal, and Thailand, and under a 20-year technology transfer and sales agreement signed with Roche in 2019 worth a USD 6,750,000 milestone, it co-markets the VENTANA SP400 LBC device.
Products & technology
- PATHPLORER AUTOAutomated liquid-based cytology (LBC) device
- PATHPLORER PLUS 4.7Semi-automatic LBC device focused on slide production speed
- PATHPLORER PLUS 4.63LBC device with external air tank
- PATHPLORER ECOCompact value-oriented LBC device
- LBC reagent kit (cell processing solution, membrane filter, slide, cell collection brush)Reagents for cancer diagnosis via liquid-based cytology
- VENTANA SP400LBC cell smearing device co-developed with Roche
Regulatory approvals
data.go.kr22 Korean MFDS device approvals · 2000–2024
- MFDSTool for biopsy2024-11-29Product approval · Class 2제인 24-1083 호
- MFDSAuto stainer for pathology2018-03-02Product approval · Class 1체외 제신 18-253 호
- MFDSSample processing instruments2016-02-02Product approval · Class 1체외 제신 16-122 호
- MFDSSpecimen transport media2015-10-30Product approval · Class 1체외 제신 15-333 호
- MFDSTool for biopsy2014-06-30Product approval · Class 2제인 14-1230 호
- MFDSSample processing instruments2014-06-20Product approval · Class 1경인 체외 제신 14-394 호
- MFDSTool for biopsy2013-02-06Product approval · Class 2제인 13-343 호
- MFDSAuto stainer for pathology2012-01-02Product approval · Class 1경인 체외 제신 12-3 호
- MFDSSample processing instruments2007-02-16Product approval · Class 1경인 체외 제신 07-39 호
- MFDS진공채혈관Revoked2006-03-20Product approval · Class 1경인 수신 06-514 호
- MFDSSample processing instruments2005-05-25Product approval · Class 1경인 체외 제신 05-69 호
- MFDS체액분석기Revoked2005-05-09Product approval · Class 1경인 제신 05-57 호
Show 10 more
- MFDS체액분석기Revoked2004-11-15Product approval · Class 1경인 제신 04-207 호
- MFDS개인용저주파자극기Revoked2004-04-30Product approval · Class 2제허 04-445 호
- MFDS의료용조합자극기Revoked2004-01-20Product approval · Class 2제허 04-85 호
- MFDS의료용필름현상기Revoked2002-03-11Product approval · Class 1경인 수신 02-512 호
- MFDS의료용영상출력기Revoked2002-02-06Product approval · Class 1경인 수신 02-257 호
- MFDS의료용필름현상기Revoked2002-02-06Product approval · Class 1경인 수신 02-258 호
- MFDS의료용필름현상기Revoked2001-12-04Product approval · Class 1경인 수신 01-3613 호
- MFDS의료용영상출력기Revoked2001-11-14Product approval · Class 1경인 수신 01-3474 호
- MFDS전산화단층엑스선촬영장치Revoked2001-05-18Product approval · Class 2수허 01-575 호
- MFDS초음파골밀도측정기Revoked2000-08-11Product approval · Class 2수허 00-882 호
R&D and key agreements
Source: DART corporate disclosure블로윙(Blowing) 기술 기반 LBC 장비 고도화 · 자궁경부암 등 세포진단 · In-house R&D center developed PATHPLORER PLUS 4.63/4.7/AUTO devices and carried out multiple government-funded projects
Publications
PubMed · affiliation-matched- Unraveling the structural complexity of and the effect of calcination temperature on calcium phosphates derived from Oreochromis niloticus bones.
Heliyon · 2024-04 · Eknapakul T, Jiamprasertboon A, Amonpattaratkit P 외 10
Patents
KIPRIS · applicant-matchedRegistered · 2025-05 · Application 1020250063038
Registered · 2025-05 · Application 1020250062646
PCT · Published · 2024-05 · Application PCT/KR2024/005922
Registered · 2023-07 · Application 1020230099543
US · Registered · 2022-11 · Application 17981361
PCT · Published · 2022-03 · Application PCT/KR2022/003893
Registered · 2021-07 · Application 1020210087790
Rejected · 2021-04 · Application 1020210046755
CN · Published · 2021-02 · Application 202180009932.0
CN · Published · 2021-02 · Application 202180009925.0
Show 32 more patents
US · Published · 2021-02 · Application 17789635
US · Published · 2021-02 · Application 17789627
EP · Registered · 2021-02 · Application 21796565.6
EP · Registered · 2021-02 · Application 21796069.9
PCT · Published · 2021-02 · Application PCT/KR2021/002159
PCT · Published · 2021-02 · Application PCT/KR2021/002160
US · Registered · 2020-12 · Application 17120043
Registered · 2020-04 · Application 1020200052928
Registered · 2020-04 · Application 1020200052920
CN · Published · 2020-01 · Application 202080006958.5
US · Registered · 2020-01 · Application 17292698
EP · Published · 2020-01 · Application 20759473.0
PCT · Published · 2020-01 · Application PCT/KR2020/000003
US · Registered · 2019-11 · Application 16689054
CN · Published · 2019-07 · Application 201980058527.0
CN · Published · 2019-07 · Application 201980058501.6
US · Registered · 2019-07 · Application 17274108
US · Registered · 2019-07 · Application 17274117
EP · Registered · 2019-07 · Application 19857442.8
EP · Published · 2019-07 · Application 19858403.9
PCT · Published · 2019-07 · Application PCT/KR2019/009582
PCT · Published · 2019-07 · Application PCT/KR2019/009581
US · Registered · 2019-03 · Application 16290774
Registered · 2019-02 · Application 1020190020649
Registered · 2019-02 · Application 1020190020610
Registered · 2018-09 · Application 1020180107442
Registered · 2018-09 · Application 1020180107443
EP · Registered · 2014-01 · Application 14756799.4
Expired · 2005-04 · Application 1020050032078
Expired · 2005-03 · Application 1020050025668
Expired · 2005-03 · Application 1020050025666
Expired · 2005-03 · Application 1020050025667
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIOAI-SearchBot51
- PerplexityPerplexityBot5
- GoogleGoogleOther2
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 10, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for BIODYNE CO., LTD. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
Founded in 1964 and KOSPI-listed in 1991, Shinhung manufactures and distributes dental equipment and materials.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
KOSDAQ-listed magnetic stimulation medical device company developing TMS-based brain rehabilitation devices and PMS pain management devices.
Founded in 1992 and KOSDAQ-listed in 2006, VATECH manufactures dental digital X-ray and CT imaging diagnostic devices.
JPI Healthcare, founded 1980, makes X-ray imaging device components and equipment, listed on KOSDAQ in August 2025.
Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.
Alpha AI, founded in 1995 and KOSDAQ-listed in 2000, manufactures biocompatible metal implants and surgical instruments.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
Xcell Therapeutics develops the domestically produced CellCor™ cell culture media series for cell and gene therapy manufacturing.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
Founded in 2001 and KOSDAQ-listed in 2011, CU Medical Systems makes AEDs and other emergency medical devices.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition